Safety and Efficacy Evaluation of Next-generation CD19-UCART

Clinical trial NCT05381181 · UNKNOWN

Trial details

NCT number: NCT05381181
Sponsor: Bioray Laboratories
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Non Hodgkin Lymphoma

Start date: 2023-12-20
Primary completion: 2024-05-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.